![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 11496 |
FusionGeneSummary for ELOVL7_DSE |
![]() |
Fusion gene information | Fusion gene name: ELOVL7_DSE | Fusion gene ID: 11496 | Hgene | Tgene | Gene symbol | ELOVL7 | DSE | Gene ID | 79993 | 29940 |
Gene name | ELOVL fatty acid elongase 7 | dermatan sulfate epimerase | |
Synonyms | - | DS-epi1|DSEP|DSEPI|EDSMC2|SART-2|SART2 | |
Cytomap | 5q12.1 | 6q22.1 | |
Type of gene | protein-coding | protein-coding | |
Description | elongation of very long chain fatty acids protein 73-keto acyl-CoA synthase ELOVL7ELOVL FA elongase 7ELOVL family member 7, elongation of long chain fatty acidsvery long chain 3-ketoacyl-CoA synthase 7very long chain 3-oxoacyl-CoA synthase 7 | dermatan-sulfate epimeraseDS epimerasechondroitin-glucuronate 5-epimerasesquamous cell carcinoma antigen recognized by T-cells 2 | |
Modification date | 20180523 | 20180519 | |
UniProtAcc | A1L3X0 | Q9UL01 | |
Ensembl transtripts involved in fusion gene | ENST00000508821, ENST00000425382, ENST00000438340, ENST00000505959, | ENST00000540275, ENST00000452085, ENST00000537543, ENST00000331677, ENST00000359564, ENST00000606265, | |
Fusion gene scores | * DoF score | 2 X 2 X 1=4 | 4 X 5 X 2=40 |
# samples | 2 | 5 | |
** MAII score | log2(2/4*10)=2.32192809488736 | log2(5/40*10)=0.321928094887362 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: ELOVL7 [Title/Abstract] AND DSE [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ELOVL7 | GO:0019367 | fatty acid elongation, saturated fatty acid | 19826053 |
Hgene | ELOVL7 | GO:0034626 | fatty acid elongation, polyunsaturated fatty acid | 20937905 |
Hgene | ELOVL7 | GO:0042761 | very long-chain fatty acid biosynthetic process | 19826053|20937905 |
Tgene | DSE | GO:0030208 | dermatan sulfate biosynthetic process | 16505484 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS3.1 | BQ340167 | ELOVL7 | chr5 | 60128856 | + | DSE | chr6 | 116599354 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-intron | ENST00000508821 | ENST00000540275 | ELOVL7 | chr5 | 60128856 | + | DSE | chr6 | 116599354 | - |
intron-intron | ENST00000508821 | ENST00000452085 | ELOVL7 | chr5 | 60128856 | + | DSE | chr6 | 116599354 | - |
intron-intron | ENST00000508821 | ENST00000537543 | ELOVL7 | chr5 | 60128856 | + | DSE | chr6 | 116599354 | - |
intron-intron | ENST00000508821 | ENST00000331677 | ELOVL7 | chr5 | 60128856 | + | DSE | chr6 | 116599354 | - |
intron-intron | ENST00000508821 | ENST00000359564 | ELOVL7 | chr5 | 60128856 | + | DSE | chr6 | 116599354 | - |
intron-intron | ENST00000508821 | ENST00000606265 | ELOVL7 | chr5 | 60128856 | + | DSE | chr6 | 116599354 | - |
intron-intron | ENST00000425382 | ENST00000540275 | ELOVL7 | chr5 | 60128856 | + | DSE | chr6 | 116599354 | - |
intron-intron | ENST00000425382 | ENST00000452085 | ELOVL7 | chr5 | 60128856 | + | DSE | chr6 | 116599354 | - |
intron-intron | ENST00000425382 | ENST00000537543 | ELOVL7 | chr5 | 60128856 | + | DSE | chr6 | 116599354 | - |
intron-intron | ENST00000425382 | ENST00000331677 | ELOVL7 | chr5 | 60128856 | + | DSE | chr6 | 116599354 | - |
intron-intron | ENST00000425382 | ENST00000359564 | ELOVL7 | chr5 | 60128856 | + | DSE | chr6 | 116599354 | - |
intron-intron | ENST00000425382 | ENST00000606265 | ELOVL7 | chr5 | 60128856 | + | DSE | chr6 | 116599354 | - |
intron-intron | ENST00000438340 | ENST00000540275 | ELOVL7 | chr5 | 60128856 | + | DSE | chr6 | 116599354 | - |
intron-intron | ENST00000438340 | ENST00000452085 | ELOVL7 | chr5 | 60128856 | + | DSE | chr6 | 116599354 | - |
intron-intron | ENST00000438340 | ENST00000537543 | ELOVL7 | chr5 | 60128856 | + | DSE | chr6 | 116599354 | - |
intron-intron | ENST00000438340 | ENST00000331677 | ELOVL7 | chr5 | 60128856 | + | DSE | chr6 | 116599354 | - |
intron-intron | ENST00000438340 | ENST00000359564 | ELOVL7 | chr5 | 60128856 | + | DSE | chr6 | 116599354 | - |
intron-intron | ENST00000438340 | ENST00000606265 | ELOVL7 | chr5 | 60128856 | + | DSE | chr6 | 116599354 | - |
intron-intron | ENST00000505959 | ENST00000540275 | ELOVL7 | chr5 | 60128856 | + | DSE | chr6 | 116599354 | - |
intron-intron | ENST00000505959 | ENST00000452085 | ELOVL7 | chr5 | 60128856 | + | DSE | chr6 | 116599354 | - |
intron-intron | ENST00000505959 | ENST00000537543 | ELOVL7 | chr5 | 60128856 | + | DSE | chr6 | 116599354 | - |
intron-intron | ENST00000505959 | ENST00000331677 | ELOVL7 | chr5 | 60128856 | + | DSE | chr6 | 116599354 | - |
intron-intron | ENST00000505959 | ENST00000359564 | ELOVL7 | chr5 | 60128856 | + | DSE | chr6 | 116599354 | - |
intron-intron | ENST00000505959 | ENST00000606265 | ELOVL7 | chr5 | 60128856 | + | DSE | chr6 | 116599354 | - |
Top |
FusionProtFeatures for ELOVL7_DSE |
![]() |
Hgene | Tgene |
ELOVL7 | DSE |
Catalyzes the first and rate-limiting reaction of thefour that constitute the long-chain fatty acids elongation cycle.This endoplasmic reticulum-bound enzymatic process, allows theaddition of 2 carbons to the chain of long- and very long-chainfatty acids/VLCFAs per cycle. Condensing enzyme with higheractivity toward C18 acyl-CoAs, especially C18:3(n-3) acyl-CoAs andC18:3(n-6)-CoAs. Also active toward C20:4-, C18:0-, C18:1-,C18:2- and C16:0-CoAs, and weakly toward C20:0-CoA. Little or noactivity toward C22:0-, C24:0-, or C26:0-CoAs. May participate inthe production of saturated and polyunsaturated VLCFAs ofdifferent chain lengths that are involved in multiple biologicalprocesses as precursors of membrane lipids and lipid mediators.{ECO:0000255|HAMAP-Rule:MF_03207, ECO:0000269|PubMed:19826053,ECO:0000269|PubMed:20937905, ECO:0000269|PubMed:21959040}. | Converts D-glucuronic acid to L-iduronic acid (IdoUA)residues. {ECO:0000269|PubMed:16505484}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for ELOVL7_DSE |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for ELOVL7_DSE |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for ELOVL7_DSE |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for ELOVL7_DSE |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | DSE | C3809845 | EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE 2 | 1 | UNIPROT |